NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Price & Overview
FRA:NZM2 • DK0060336014
The current stock price of NZM2.DE is 47.09 EUR. Today NZM2.DE is down by -0.99%. In the past month the price decreased by -7.23%.
NZM2.DE Key Statistics
- Market Cap
- 19.522B
- P/E
- 25.05
- Fwd P/E
- 23.09
- EPS (TTM)
- 1.88
- Dividend Yield
- 1.76%
NZM2.DE Stock Performance
NZM2.DE Stock Chart
NZM2.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to NZM2.DE.
NZM2.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NZM2.DE. NZM2.DE has only an average score on both its financial health and profitability.
NZM2.DE Earnings
On February 25, 2026 NZM2.DE reported an EPS of 0.45 and a revenue of 996.60M. The company missed EPS expectations (-16.62% surprise) and missed revenue expectations (-3.15% surprise).
NZM2.DE Forecast & Estimates
24 analysts have analysed NZM2.DE and the average price target is 63.75 EUR. This implies a price increase of 35.39% is expected in the next year compared to the current price of 47.09.
For the next year, analysts expect an EPS growth of 8.49% and a revenue growth 6.98% for NZM2.DE
NZM2.DE Groups
Sector & Classification
NZM2.DE Financial Highlights
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.88. The EPS increased by 87.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.04% | ||
| ROA | 3.57% | ||
| ROE | 5.38% | ||
| Debt/Equity | 0.12 |
NZM2.DE Ownership
NZM2.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SY1 | SYMRISE AG | 17.87 | 9.803B | ||
| AKZA | AKZO NOBEL N.V. | 12.41 | 8.895B | ||
| AKU1 | AKZO NOBEL N.V. | 12.34 | 8.881B | ||
| EVK | EVONIK INDUSTRIES AG | 12.59 | 6.585B | ||
| SYENS | SYENSQO SA | 9.26 | 4.945B | ||
| UMI | UMICORE | 12.34 | 4.253B | ||
| NVJP | UMICORE | 12.37 | 4.253B | ||
| AKE | ARKEMA | 11.43 | 4.149B | ||
| WCH | WACKER CHEMIE AG | 121.83 | 3.817B | ||
| RBT | ROBERTET SA | 16.22 | 1.743B | ||
| ACT | ALZCHEM GROUP AG | 25.19 | 1.602B | ||
| CRBN | CORBION NV | 12.48 | 1.096B | ||
| UZU | UZIN UTZ SE | 13.12 | 375.48M |
Related stock screener links
View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NZM2.DE
Company Profile
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
Company Info
IPO: 1905-05-27
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 10582
NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ
What does NOVONESIS (NOVOZYMES) B do?
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
What is the current price of NZM2 stock?
The current stock price of NZM2.DE is 47.09 EUR. The price decreased by -0.99% in the last trading session.
Does NZM2 stock pay dividends?
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.76%. The yearly dividend amount is currently 0.86.
How is the ChartMill rating for NOVONESIS (NOVOZYMES) B?
NZM2.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Is NOVONESIS (NOVOZYMES) B (NZM2.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.
Can you provide the upcoming earnings date for NOVONESIS (NOVOZYMES) B?
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-05-05.